Brief: Waverley Pharma Announces Tentative ANDA Approval For Pemetrexed In United States
12/11/2020 18:55
Nov 12 (Reuters) - Waverley Pharma Inc WAVE.V :
* ANNOUNCES TENTATIVE ANDA APPROVAL FOR PEMETREXED IN UNITED
STATES
Source text for Eikon: urn:newsml:reuters.com:*:nCNWYFWr1a
Further company coverage: WAVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Waverley Pharma
See all newsBrief: Waverley Pharma Announces Chief Financial Officer Change
Brief: Waverley Pharma Acquires Us Based Pharmacy
Brief: Waverley Pharma Business Update
Brief: Waverley Pharma Provides Update On Its Parp-1 Inhibitor Program
Brief: Waverley Pharma - Co's Unit Awarded Exclusive Distribution Rights For Two Strengths Of Pemetrexed By NHS England